10 employees
Xytis is a biopharmaceutical company focusing on the discovery and development of innovative central nervous system drug candidates.
2004
$25M
from 4 investors over 4 rounds
Xytis, Inc. raised $25M on January 9, 2006
Investors: Ventech, La Caisse des Dépôts (French financial institute), Atlas Venture and Sanderling Ventures